Monitoring Agency Report for Quarter Ended June 30, 2025
This is a standard monitoring report required for IPO fund utilization, and it does not indicate any significant financial or strategic changes for the company.
The announcement is a routine regulatory filing regarding the monitoring of IPO fund utilization and reports on factual data.
* CARE Ratings Limited, the Monitoring Agency, has submitted its report on the utilization of IPO proceeds for the quarter ended June 30, 2025. * The IPO raised ₹600 crore. * There was no deviation from the stated objectives of the IPO. * As of June 30, 2025, ₹5.52 crore earmarked for General Corporate Purposes (GCP) remains unutilized. * The company extended the timeline for utilizing the remaining funds through a board resolution dated April 21, 2025, and the utilization is now expected to be completed by the end of fiscal year 2026 or thereafter. * ₹0.27 crore was spent towards capex out of the GCP amount allocated during the period 04/01/2025 to 06/30/2025. * Unspent issue expenses of ₹1.60 crore.
What to do with a filing like this
Rashi Peripherals Limited filed this with the NSE as a statutory disclosure, categorised under regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rashi Peripherals Limited. Read the original for the full detail.